Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual-release hydrocortisone versus immediate-release glucocorticoid replacement for glucose control in adrenal insufficiency with diabetes
2016-004772-21Phase 4Terminated
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Start
- Jun 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydrocortisone and cortisone in hypoadrenocorticism (2 arms), sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Primary endpoint: Change in HbA1c. Started Jun 2021; status: terminated.
02
Drugs
hydrocortisonecortisone
03
Conditions
hypoadrenocorticism
Beyond the preview
Go deeper on 2016-004772-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004772-21.